Literature DB >> 10591342

Oral contraceptives and women's health in Japan.

A Goto1, M R Reich, I Aitken.   

Abstract

Japan approved the use of low-dose oral contraceptives (OCs) in June 1999, after more than 35 years of debate. The debate leaves a legacy of misinformation about and various sources of resistance to OCs. Benefits are expected to include greater control for women over their fertility and a reduction in the high rates of unplanned pregnancies and abortions. Successful implementation of the new policy will require a new emphasis on women's health, including the provision of accurate information about OCs and their associated adverse effects, a women-centered approach to gynecological practice, and the promotion of condoms as protection from sexually transmitted diseases, rather than as contraception alone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591342     DOI: 10.1001/jama.282.22.2173

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  3 in total

1.  Obstetrician-gynecologists' views on contraception and natural family planning: a national survey.

Authors:  Ryan E Lawrence; Kenneth A Rasinski; John D Yoon; Farr A Curlin
Journal:  Am J Obstet Gynecol       Date:  2010-11-11       Impact factor: 8.661

Review 2.  Do differences in risk factors explain the lower rates of coronary heart disease in Japanese versus U.S. women?

Authors:  Akira Sekikawa; Bradley J Willcox; Takeshi Usui; John Jeffrey Carr; Emma J M Barinas-Mitchell; Kamal H Masaki; Makoto Watanabe; Russell P Tracy; Marianne H Bertolet; Rhobert W Evans; Kunihiko Nishimura; Kim Sutton-Tyrrell; Lewis H Kuller; Yoshihiro Miyamoto
Journal:  J Womens Health (Larchmt)       Date:  2013-09-28       Impact factor: 2.681

3.  Menstrual and reproductive factors and risk of vertebral fractures in Japanese women: the Japan Public Health Center-based prospective (JPHC) study.

Authors:  Y Shimizu; N Sawada; K Nakamura; Y Watanabe; K Kitamura; M Iwasaki; S Tsugane
Journal:  Osteoporos Int       Date:  2018-08-24       Impact factor: 4.507

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.